17. Targeted therapy for non-Hodgkin lymphoma - Dr Cathy Burton

In this lecture, the discussion focuses on the increasing number of targeted therapies for non-Hodgkin lymphoma (NHL), and most of these have fewer side effects. The laboratory techniques to diagnose and identify targets for which trials to decide the best use of the targeted therapies is required.